JP2004517057A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517057A5 JP2004517057A5 JP2002538979A JP2002538979A JP2004517057A5 JP 2004517057 A5 JP2004517057 A5 JP 2004517057A5 JP 2002538979 A JP2002538979 A JP 2002538979A JP 2002538979 A JP2002538979 A JP 2002538979A JP 2004517057 A5 JP2004517057 A5 JP 2004517057A5
- Authority
- JP
- Japan
- Prior art keywords
- vector system
- variant
- protein
- rabies
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002569 neuron Anatomy 0.000 claims 11
- 108091006027 G proteins Proteins 0.000 claims 8
- 102000030782 GTP binding Human genes 0.000 claims 8
- 108091000058 GTP-Binding Proteins 0.000 claims 8
- 206010037742 Rabies Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 230000007441 retrograde transport Effects 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000002161 motor neuron Anatomy 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 210000001044 sensory neuron Anatomy 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0026943A GB0026943D0 (en) | 2000-11-03 | 2000-11-03 | Vector system |
| GB0102339A GB0102339D0 (en) | 2001-01-30 | 2001-01-30 | Vector system |
| GB0122238A GB0122238D0 (en) | 2001-09-14 | 2001-09-14 | Vector system |
| PCT/GB2001/004866 WO2002036170A2 (en) | 2000-11-03 | 2001-11-02 | Vector system for transducing the positive neurons |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008131960A Division JP2008303215A (ja) | 2000-11-03 | 2008-05-20 | ベクターシステム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517057A JP2004517057A (ja) | 2004-06-10 |
| JP2004517057A5 true JP2004517057A5 (https=) | 2005-05-26 |
Family
ID=27255961
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002538979A Pending JP2004517057A (ja) | 2000-11-03 | 2001-11-02 | ベクターシステム |
| JP2008131960A Pending JP2008303215A (ja) | 2000-11-03 | 2008-05-20 | ベクターシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008131960A Pending JP2008303215A (ja) | 2000-11-03 | 2008-05-20 | ベクターシステム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040071675A1 (https=) |
| EP (1) | EP1333863A2 (https=) |
| JP (2) | JP2004517057A (https=) |
| AU (1) | AU2002214132A1 (https=) |
| WO (1) | WO2002036170A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003025188A1 (en) * | 2001-09-14 | 2003-03-27 | Oxford Biomedica (Uk) Limited | Use of a lentiviral vector in the treatment of pain |
| FR2841246B1 (fr) * | 2002-06-20 | 2004-12-31 | Centre Nat Rech Scient | Peptide issu de la proteine g du virus de la rage, ligand du recepteur de basse affinite des neurotrophines(p75ntr) et ses applications |
| JP2006502240A (ja) * | 2002-10-04 | 2006-01-19 | オックスフォード バイオメディカ （ユーケー） リミテッド | ベクター系 |
| CA2943039C (en) | 2005-10-14 | 2018-11-06 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Rabies virus compositions and methods |
| EP2239330A1 (en) | 2009-04-07 | 2010-10-13 | Institut Pasteur | Neuron generation, regeneration and protection |
| JP5123922B2 (ja) * | 2009-12-02 | 2013-01-23 | 独立行政法人科学技術振興機構 | 融合糖タンパク質から成るエンベロープを有する逆行性輸送ウィルスベクター系 |
| JP5216072B2 (ja) * | 2010-11-26 | 2013-06-19 | 独立行政法人科学技術振興機構 | 神経細胞特異的な逆行性輸送ベクター |
| EP3466443B1 (en) | 2012-02-14 | 2020-12-16 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom |
| WO2016054079A1 (en) | 2014-09-29 | 2016-04-07 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
| CA2966191A1 (en) * | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817491A (en) * | 1990-09-21 | 1998-10-06 | The Regents Of The University Of California | VSV G pseusdotyped retroviral vectors |
| WO1999061639A2 (en) * | 1998-05-22 | 1999-12-02 | Oxford Biomedica (Uk) Limited | Retroviral delivery system |
| US20040076613A1 (en) * | 2000-11-03 | 2004-04-22 | Nicholas Mazarakis | Vector system |
| US6818209B1 (en) * | 1998-05-22 | 2004-11-16 | Oxford Biomedica (Uk) Limited | Retroviral delivery system |
| EP0961830A1 (en) * | 1997-01-29 | 1999-12-08 | Neurosearch A/S | EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES |
-
2001
- 2001-11-02 EP EP01982589A patent/EP1333863A2/en not_active Ceased
- 2001-11-02 AU AU2002214132A patent/AU2002214132A1/en not_active Abandoned
- 2001-11-02 WO PCT/GB2001/004866 patent/WO2002036170A2/en not_active Ceased
- 2001-11-02 JP JP2002538979A patent/JP2004517057A/ja active Pending
-
2003
- 2003-05-05 US US10/429,608 patent/US20040071675A1/en not_active Abandoned
-
2008
- 2008-05-20 JP JP2008131960A patent/JP2008303215A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kawada et al. | Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease | |
| Goldbach-Mansky | Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1 | |
| Bessis et al. | The type II decoy receptor of IL‐1 inhibits murine collagen‐induced arthritis | |
| JP2004517057A5 (https=) | ||
| CN111542335A (zh) | 炎症性肠病的治疗药 | |
| DE60044957D1 (de) | Bereitstellung von Peptiden mit Kleeblattstruktur | |
| JPH05505170A (ja) | 成長因子による口内粘膜炎の治療および予防 | |
| RU2006101149A (ru) | Рекомбинантный адено-ассоциированный вирусный вектор для лечения болезни альцгеймера | |
| TW202038981A (zh) | 治療失智症的組合物及方法 | |
| US20110268696A1 (en) | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 | |
| KR970701724A (ko) | 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin) | |
| JP2004537284A5 (https=) | ||
| JP4215857B2 (ja) | 学習・記憶能力改善剤 | |
| BR0317132A (pt) | Métodos de diagnóstico e tratamento de doença pulmonar intersticial | |
| Schluesener | The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccine | |
| EP4054564A1 (en) | Treatment of autoinflammatory disorders | |
| CN116196424B (zh) | 蛋白转运抑制剂在制备用于治疗炎性骨吸收的药物中的用途 | |
| JP2008500289A (ja) | 炎症性気道疾患の治療 | |
| Gribonika | Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity | |
| Rethnam et al. | Differential expression of neuropeptide Y Y1 receptors during pulpal inflammation | |
| JP2019512216A5 (https=) | ||
| Bonnin et al. | Mucosal modulation of immune responses to heat shock proteins in autoimmune arthritis | |
| EP0383481A3 (en) | Anesthetic oral compositions | |
| US20100004174A1 (en) | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases | |
| CA2305786A1 (fr) | Utilisation des bloqueurs des canaux potassium neuronaux et lymphocytaires dans le traitement des maladies neurologiques d'origine immunitaire |